Demystifying Latent Tuberculosis Infections and Treatment for the Primary Care Provider

Presenter: Janice Louie, MD, MPH & Susan McElhany, DMD

Online CME Credit

Fee: Free

Provides 0.75 hours of CE/CME credit (Presented: February 25, 2025; Reviewed March 13, 2025; Expires March 13, 2028)

Overview

This recorded webinar is a collaboration with the Curry International Tuberculosis Center and The Pacific AIDS Education and Training Center-Nevada. Persons with HIV and co-infected with TB bacteria are more likely to progress to TB disease. This webinar addresses the impact of latent TB infection on persons with HIV.

Learning Objectives

Following participation in this course, participants should be able to:

  • Explain why identification and treatment of latent TB infection (LTBI) is key to eliminating TB disease
  • Explain the impact of LTBI on persons with HIV and the essential components of an individual TB Risk Assessment Tool
  • Explain the advantages and disadvantages of TB blood tests, IGRAs
  • Describe other diagnostics necessary to distinguish LTBI from active TB disease given that TB skin tests (TST) or TB blood tests (IGRAs) cannot rule-out active tuberculosis disease.
  • Discuss the current recommended short-course treatments for LTBI and the advantages versus disadvantages, to inform appropriate use in clinical practice

The Pacific AETC-NV offers engaging and interactive online learning opportunities to increase healthcare providers' knowledge and awareness of HIV and STI-related health topics. To view all session topics available, please click on Pacific AETC Nevada’s E-Learning page for more online and on-demand learning opportunities.

Presenter

Janice Louie, MD, MPH is Medical Director of the San Francisco Department of Public Health Tuberculosis Prevention and Control Program, and Assistant Clinical Professor in the University of California San Francisco Department of Medicine. Her primary focus is to ensure continued excellence in the clinical management of tuberculosis, provide mentorship and training to fellows, residents, and other trainees, and advancing clinical practices in tuberculosis with a focus on the elderly.
 
Susan McElhany, DMD, is the Tuberculosis Program Manager for the Office of State Epidemiology, within the Nevada Division of Public and Behavioral Health, Department of Health and Human Services.

The Pacific AETC is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award $3,887,700.00. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by HRSA, HHS, or the U.S. Government. For more information, please visit HRSA.gov.